Ogata H - Search Results

1

Early intervention with adalimumab may contribute to favorable clinical efficacy in patients with Crohn's disease.

Miyoshi J, Hisamatsu T, Matsuoka K, Naganuma M, Maruyama Y, Yoneno K, Mori K, Kiyohara H, Nanki K, Okamoto S, Yajima T, Iwao Y, Ogata H, Hibi T, Kanai T. Miyoshi J, et al. Among authors: ogata h. Digestion. 2014;90(2):130-6. doi: 10.1159/000365783. Epub 2014 Oct 1. Digestion. 2014. PMID: 25323803

2

Animal models of inflammatory bowel disease.

Hibi T, Ogata H, Sakuraba A. Hibi T, et al. Among authors: ogata h. J Gastroenterol. 2002;37(6):409-17. doi: 10.1007/s005350200060. J Gastroenterol. 2002. PMID: 12108674 Review. No abstract available.

3

[Molecular biological study of physiopathology of inflammatory bowel diseases (Crohn disease and ulcerative colitis)].

Hibi T, Inoue N, Ogata H. Hibi T, et al. Among authors: ogata h. Nihon Naika Gakkai Zasshi. 2002 Sep 20;91 Suppl:78-83. Nihon Naika Gakkai Zasshi. 2002. PMID: 12577929 Review. Japanese. No abstract available.

4

Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.

Hibi T, Inoue N, Ogata H, Naganuma M. Hibi T, et al. Among authors: ogata h. J Gastroenterol. 2003 Mar;38 Suppl 15:36-42. J Gastroenterol. 2003. PMID: 12698869 Review.

5

Cytokine and anti-cytokine therapies for inflammatory bowel disease.

Ogata H, Hibi T. Ogata H, et al. Curr Pharm Des. 2003;9(14):1107-13. doi: 10.2174/1381612033455035. Curr Pharm Des. 2003. PMID: 12769750 Review.

6

A specific genetic alteration on chromosome 6 in ulcerative colitis-associated colorectal cancers.

Ezaki T, Watanabe M, Inoue N, Kanai T, Ogata H, Iwao Y, Ishii H, Hibi T. Ezaki T, et al. Among authors: ogata h. Cancer Res. 2003 Jul 1;63(13):3747-9. Cancer Res. 2003. PMID: 12839969

7

Does an elemental diet affect operation and/or recurrence rate in Crohn's disease in Japan?

Ogata H, Hibi T. Ogata H, et al. J Gastroenterol. 2003;38(10):1019-21. doi: 10.1007/s00535-003-1210-z. J Gastroenterol. 2003. PMID: 14614616 No abstract available.

8

[Pathophysiology of inflammatory bowel diseases and the therapeutic strategy].

Hibi T, Ogata H. Hibi T, et al. Among authors: ogata h. Nihon Naika Gakkai Zasshi. 2004 Mar 10;93(3):499-504. doi: 10.2169/naika.93.499. Nihon Naika Gakkai Zasshi. 2004. PMID: 15052810 Review. Japanese. No abstract available.

9

Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.

Naganuma M, Funakoshi S, Sakuraba A, Takagi H, Inoue N, Ogata H, Iwao Y, Ishi H, Hibi T. Naganuma M, et al. Among authors: ogata h. Inflamm Bowel Dis. 2004 May;10(3):251-7. doi: 10.1097/00054725-200405000-00012. Inflamm Bowel Dis. 2004. PMID: 15290920 Clinical Trial.

10

[Endoscopic diagnosis of colitic cancer and dysplasia].

Iwao Y, Matsuoka K, Ogata H, Hibi T. Iwao Y, et al. Among authors: ogata h. Nihon Rinsho. 2005 May;63(5):738-9. Nihon Rinsho. 2005. PMID: 15881163 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,821 results

Search Page

Filters